H. Lode
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 125
- Pneumonia and Respiratory Infections 94
- Pneumocystis jirovecii pneumonia detection and treatment 20
- Pharmacology 110
- Antibiotics Pharmacokinetics and Efficacy 107
- Co-authors
- Ralf Stahlmann (20 shared papers)P. Koeppe (51 shared papers)T. Schaberg (32 shared papers)K. Börner (37 shared papers)A de Roux (13 shared papers)G. Höffken (21 shared papers)H. Mauch (17 shared papers)Mathias W. Pletz (12 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (25 papers)Journal of Antimicrobial Chemotherapy (14 papers)European Respiratory Journal (14 papers)Clinical Microbiology and Infection (13 papers)International Journal of Antimicrobial Agents (12 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
H. Lode
256 papers receiving 7.7k citations
H. Lode's Hit Papers
Peers
Comparison fields: 5 of 148
- Molecular Medicine 946
- Applied Microbiology and Biotechnology 285
- Critical Care and Intensive Care Medicine 588
- Pharmacology 2.1k
- Infectious Diseases 2.0k
Countries citing papers authored by H. Lode
This map shows the geographic impact of H. Lode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lode more than expected).
Fields of papers citing papers by H. Lode
This network shows the impact of papers produced by H. Lode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lode. The network helps show where H. Lode may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Lode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 277 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis Hit paper breakdown → | 2002 | 644 |
| 2 | 1996 | 296 | |
| 3 | 1998 | 277 | |
| 4 | 1985 | 238 | |
| 5 | 2008 | 199 | |
| 6 | 1999 | 178 | |
| 7 | 2012 | 168 | |
| 8 | 2010 | 163 | |
| 9 | 2000 | 154 | |
| 10 | 2008 | 145 | |
| 11 | 2010 | 128 | |
| 12 | 2004 | 127 | |
| 13 | 2004 | 114 | |
| 14 | 1996 | 113 | |
| 15 | 1995 | 106 | |
| 16 | 2013 | 103 | |
| 17 | 2004 | 95 | |
| 18 | 2006 | 95 | |
| 19 | 2003 | 90 | |
| 20 | 2006 | 88 |
About H. Lode
H. Lode is a scholar working on Epidemiology, Pharmacology, Molecular Medicine, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 277 papers that have together received 8.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (107 papers), Pneumonia and Respiratory Infections (94 papers), Antibiotic Resistance in Bacteria (53 papers), Nosocomial Infections in ICU (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (20 papers), Antibiotic Use and Resistance (17 papers), Drug Transport and Resistance Mechanisms (15 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). The work is most often cited by research in Molecular Medicine (946 citations), Applied Microbiology and Biotechnology (285 citations), Critical Care and Intensive Care Medicine (588 citations), Pharmacology (2.1k citations) and Infectious Diseases (2.0k citations). H. Lode has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ralf Stahlmann, P. Koeppe, T. Schaberg, K. Börner, A de Roux, G. Höffken, H. Mauch, Mathias W. Pletz, David W. Denning and Klaus Borner. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Respiratory Journal, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.